<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Signal transducer and activator of transcription 6 (Stat6) is critical in Th2 polarization of immune cells and active Stat6 activity has been suggested in anti-<z:e sem="disease" ids="C1519680" disease_type="Disease or Syndrome" abbrv="">tumor immunity</z:e> in animal models </plain></SENT>
<SENT sid="1" pm="."><plain>The present study aims at investigating the impact of natural Stat6 activity on <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> microenvironment in human <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cells in vitro and in vivo </plain></SENT>
<SENT sid="2" pm="."><plain>Using <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cell lines HT-29 and Caco-2 whose IL-4/Stat6 activities were known and <z:mp ids='MP_0003815'>nude</z:mp> mice as a model, we examined correlative relationships between Stat6 activities and gene expression profiles together with cellular behaviors in vitro and in vivo </plain></SENT>
<SENT sid="3" pm="."><plain>HT-29 cells carrying active Stat6 signaling displayed spontaneous expression profiles favoring Th2 cytokines, cell cycle promotion, anti-<z:mpath ids='MPATH_3'>apoptosis</z:mpath> and pro-<z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> with increased <z:chebi fb="2" ids="33699">mRNA</z:chebi> levels of IL-4, IL-13, GATA-3, CDK4, CD44v6 and S100A4 using RT-PCR </plain></SENT>
<SENT sid="4" pm="."><plain>In contrast, Caco-2 cells carrying defective Stat6 signaling exhibited spontaneous expression profiles favoring Th1 and Th17 cytokines, cell cycle inhibition, pro-<z:mpath ids='MPATH_3'>apoptosis</z:mpath> and anti-<z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> with elevated <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression of IFNγ, TNFα, IL-12A, IL-17, IL-23, T-bet, CDKN1A, CDKNIB, CDKN2A and NM23-H1 </plain></SENT>
<SENT sid="5" pm="."><plain>Xenograft <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> of Stat6-active HT-29 cells showed a growth advantage over those of Stat6-defective Caco-2 cells </plain></SENT>
<SENT sid="6" pm="."><plain>Furthermore, mice bearing HT-29 tumors expressed increased levels of Th2 cytokines IL-4 and IL-5 in the blood and pro-growth and/or pro-<z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> proteins CDK4 and CD44v6 in the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>To the contrary, mice bearing Caco-2 tumors expressed heightened levels of Th1 cytokines IFNγ and TNF in the blood and pro-<z:mpath ids='MPATH_3'>apoptosis</z:mpath> and anti-metastatic proteins p53 and p27(kip1) in the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain><z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">Colorectal cancer</z:e> cells carrying active Stat6 signaling may create a microenvironment favoring Th2 cytokines and promoting expression of genes related to pro-growth, pro-<z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> and anti-<z:mpath ids='MPATH_3'>apoptosis</z:mpath>, which leads to a <z:e sem="disease" ids="C0598934" disease_type="Neoplastic Process" abbrv="">tumor growth</z:e> advantage in vivo </plain></SENT>
<SENT sid="9" pm="."><plain>These findings may imply why Stat6 pathway is constitutively activated in a number of human <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> </plain></SENT>
</text></document>